Cheryl Renz

Cheryl Renz has a comprehensive work experience spanning several different companies.

Cheryl is currently serving as the Chief Medical Officer at Pregistry, a CorEvitas Company, since April 2022. Prior to this, they held the role of President at Convene Pharma Consulting, LLC, starting in March 2022.

Before joining Pregistry and Convene Pharma Consulting, LLC, Cheryl had a long tenure at AbbVie. Cheryl held the position of Head, Benefit Risk Management organization / Executive Medical Director from March 2017 to September 2021. Prior to that, they served as the Head of Risk Management, Global Pharmacovigilance from June 2013 to March 2017.

Their career at Abbott started in 1998, where they held various roles of increasing responsibility. Cheryl served as a Program Director / Senior Medical Director from June 2008 to June 2013. Before that, they were a Global Project Head from June 2001 to June 2008. Cheryl started their journey at Abbott as an Associate Medical Director from June 1998 to June 2001.

Cheryl Renz obtained their Bachelor of Science (BS) and Master of Science (MS) degrees in Biochemistry from the University of Rochester, where they studied from 1981 to 1986. Cheryl also attended the Eastman School of Music and received a Diploma with Honors in Piano from the Preparatory Department. In 1986, Cheryl enrolled in The University of Chicago Pritzker School of Medicine, where they pursued a Doctor of Medicine (MD) degree, completing their medical education in 1990.